Table 1. Clinical and demographic parameters of the study population.
Parameter | |
---|---|
Age of recipient (yrs) | 57.34 ± 10.37 |
Age of donor (yrs) | 61.65 ± 9.24 |
Males (%), recipient | 78 (65.5) |
Females (%), recipient | 41 (34.5) |
Males (%), donor | 54 (63.53) |
Females (%), donor | 31 (36.47) |
Time on dialysis (yrs) | 4.22 ± 3.97 |
History of CV events in recipient | 24 (20.2) |
History of CV events in donor | 18 (20.5) |
Weight, recipient (kg) | 76.49 ± 15.35 |
BMI, recipient | 28.61 ± 5.13 |
Hypertension, recipient | 96 (80.7) |
Hypertension, donor | 50 (56.8) |
DM, recipient | 19 (16) |
DM, donor | 18 (20.5) |
Hyperlipidemia, recipient | 52 (43.7) |
Hyperlipidemia, donor | 18 (20.5) |
HLA | |
1–3 | 84 (70.59) |
4–5 | 35 (29.41) |
Delayed graft function | 43 (36.1) |
Acute rejection | 18 (15.1) |
Graft loss | 27 (22.7) |
Cold ischemia time (hours) | 17.27 ± 19.33 |
Creatinine serum concentration (mg/dl) | 1.68 ± 0.77 |
eGFR (ml/min) (MDRD) | 51.38 ± 17.69 |
BMI, body mass index; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate.